MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2019 International Congress

    Serum MIR-96-5P and MIR-339-5P as a Potential Biomarker for Multiple System Atrophy and Parkinson’s Disease

    A. Vallelunga, T. Iannitti, S. Capece, G. Somma, G. Dati, P. Barone, W. Meissner, M. Pellecchia (Salerno, Italy)

    Objective: The aim of our study was to to determine if serum mir-96-5p and mir-339-5p can be used as biomarkers for early diagnosis of Parkinson’s…
  • 2019 International Congress

    5 cases Static Encephalopathy of childhood with NeuroDegeneration in Adulthood (OMIM 300894) in children

    M. Bobylova, N. Perumova, T. Prygunova, K. Mukhin (Moscow, Russian Federation)

    Objective: 5 russian female patients aged 3 to 6 years with different mutations of the WDR45 gene were examined. Background: To study the clinical picture…
  • 2019 International Congress

    Case Series of 3 Individuals of African Descent with Dentatorubral-Pallidoluysian Atrophy

    C. Kutz, C. Bundukamara (Colorado Springs, CO, USA)

    Objective: To analyze the demographics, genetic history, co-morbidities, and clinical presentation of three individuals of African descent with Dentatorubral-Pallidoluysian Atrophy (DRPLA). Background: DRPLA is a…
  • 2019 International Congress

    Transcranial sonography in carriers of Gaucher disease

    F. Omrani, N. Mohammadzade, M. Rohani, Z. Omrani, B. Zamani (Tehran, Islamic Republic of Iran)

    Objective: The objectives are to  compare maximal area of SN hyperechogenicity (aSNmax) and diameter of third ventricle (DTV) between GBA mutation carriers and healthy controls.…
  • 2019 International Congress

    Hypophosphatasia presenting as parkinsonism with compound heterozygous mutations in ALPL gene

    WF. Yu, ZX. Zhao, LW. Liu, JL. Hu, FF. Wang, YM. Liu (Jinan, China)

    Objective: We report a hypophosphatasia patient presenting as parkinsonism, characterized by compound heterozygous mutations in ALPL gene. Background: Hypophosphatasia (HPP) is a rare metabolism disease,…
  • 2019 International Congress

    In the shadow of Parkinson disease: what to tell patients with REM sleep behavior disorder?

    D. Barone, A. Lee, N. Hellmers, S. Lakhani, H. Sarva, C. Henchcliffe (New York, NY, USA)

    Objective: To describe challenges to patient counseling in REM sleep behavior disorder (RBD). Background: RBD is a significant risk factor for development of Parkinson disease…
  • 2019 International Congress

    Iron Supplementation for the Treatment of Restless Legs Syndrome – A Systematic Review and Meta-Analysis

    M. Kestenbaum, N. Lev (Kfar Saba, Israel)

    Objective: To gather the evidence for the efficacy and safety of iron supplementation for restless legs syndrome (RLS). Background: Iron supplementation is used for the…
  • 2019 International Congress

    Does socio-economic status have impact on quality of life in persons with Parkinson’s disease?

    R. Aggarwal, V. Goyal, A. Srivastava, M. Behari (Delhi, India)

    Objective: To evaluate the effect of socio-economic status (SES) on quality of life (QoL) in persons with Parkinson’s disease (PWP). Background: Parkinson’s disease (PD) has…
  • 2019 International Congress

    The impact of clinical care coordination on patient quality of life in the Atypical Parkinsonism clinic

    M. Harris, J. Donnelly, L. Massey, B. Ghosh (Southampton, United Kingdom)

    Objective: To assess the impact of clinical care coordination on patient quality of life in the Atypical Parkinsonism clinic. Background: The Atypical Parkinsonian Syndromes of…
  • 2019 International Congress

    Changes in close relationships among patients with Parkinson’s disease and their partners following initiation of device-aided treatment

    J. Timpka, M. Scharfenort, T. Sahlström, V. Hernström, T. Henriksen, D. Nyholm, P. Odin (Lund, Sweden)

    Objective: Our primary objective was to study whether there is a difference in how close relationships are perceived by Parkinson’s disease (PD) patients with device-aided…
  • « Previous Page
  • 1
  • …
  • 70
  • 71
  • 72
  • 73
  • 74
  • …
  • 217
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • Nilotinib for treating MSA: A preclinical proof of concept study
  • An atypical and interesting feature of Parkinson´s disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An atypical and interesting feature of Parkinson´s disease
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley